chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 45.0
Sex: F
Vaccine: FLU(H1N1)
Symptoms: Coordination abnormal, Cough, Cranial nerve disorder, Diaphragmalgia, Diarrhoea
Clinical narrative: Initial report received on 08 December 2009 from CDC, VAERS number 368466-1. A 45-year old female patient had received a first dose of H1N1 (lot number UP005A) on 19 October 2009. The patient has concurrent condition of hyperlipidemia and medical history of GERD (gastroesophageal reflux disease) with Barrett's esophagus, high cholesterol, Influenza A (July 2009), hypertension, hypertriglyceridemia, and allergy to morphine. Surgical history includes: hysterectomy, cholecystectomy, colon polypectomies, cystoscopy with ureter stent, and "T&A" (tonsillectomy and adenoidectomy). The following is verbatim from the report for description of symptoms and reaction. "Onset date of symptoms: 12 November 2009, interval days 24. Seriousness criteria: Hospitalization with extended stay, disabled, and life threatening." "Pain in extremities, numbness, tingling, paralysis. 19 November 2009 ED records received service date 15 November 2009. Assessment: SOB, tingling all extremities, losing coordination. Patient presents short of breath, tingling in arms and legs, unable to control movements. Breathing labored. Skin warm, flushed. Unable to hold arms up. Transported to higher level facility. 23 November 2009 medical records received service dates 15 November 2009 to 20 November 2009. Assessment: Probable Guillain-Barre syndrome with possible associated neurogenic bladder. Community acquired left lower lobe pneumonia. Three days ago patient felt prickly feeling in feet which progressed up legs. Muscle pain and achiness all over. Feet and hands became numb, muscles weak, difficulty moving hands and feet. Diaphragm sore, short of breath, painful to take a deep breath. Choking, gagging, tightness in throat. Fever, chills, nonproductive cough. Urinary retention. Suprapubic discomfort. Overweight. Decreased hand grip strength, cannot lift legs off bed, deep tendon reflexes absent. Cranial Nerve V-sensory deficit. Decreased sensation to pin prick and touch. IVIG (intravenous Immunoglobulin)given. Headache. Tingling and numbness resolving, strength returning. Diarrhea. Laboratory data: ECG (electrocardiogram) abnormal, sinus tachycardia, borderline T abnormalities, CSF (cerebral spinal fluid) RBC (red blood cells) 36/uL (H), CBC (complete blood count) with WBC (white blood cell count) 2.2 K/uL (L), Mono 22.0% (H), Eos 6.0% (H), and Neut 0.9 K/uL (L), C-Reactive Protein increased." The patient has not recovered. This case has not been reviewed by agency.
Age: 45.0
Sex: F
Vaccine: FLU(H1N1)
Symptoms: Dyskinesia, Dyspnoea, Electrocardiogram abnormal, Eosinophil percentage increased, Flushing
Clinical narrative: Initial report received on 08 December 2009 from CDC, VAERS number 368466-1. A 45-year old female patient had received a first dose of H1N1 (lot number UP005A) on 19 October 2009. The patient has concurrent condition of hyperlipidemia and medical history of GERD (gastroesophageal reflux disease) with Barrett's esophagus, high cholesterol, Influenza A (July 2009), hypertension, hypertriglyceridemia, and allergy to morphine. Surgical history includes: hysterectomy, cholecystectomy, colon polypectomies, cystoscopy with ureter stent, and "T&A" (tonsillectomy and adenoidectomy). The following is verbatim from the report for description of symptoms and reaction. "Onset date of symptoms: 12 November 2009, interval days 24. Seriousness criteria: Hospitalization with extended stay, disabled, and life threatening." "Pain in extremities, numbness, tingling, paralysis. 19 November 2009 ED records received service date 15 November 2009. Assessment: SOB, tingling all extremities, losing coordination. Patient presents short of breath, tingling in arms and legs, unable to control movements. Breathing labored. Skin warm, flushed. Unable to hold arms up. Transported to higher level facility. 23 November 2009 medical records received service dates 15 November 2009 to 20 November 2009. Assessment: Probable Guillain-Barre syndrome with possible associated neurogenic bladder. Community acquired left lower lobe pneumonia. Three days ago patient felt prickly feeling in feet which progressed up legs. Muscle pain and achiness all over. Feet and hands became numb, muscles weak, difficulty moving hands and feet. Diaphragm sore, short of breath, painful to take a deep breath. Choking, gagging, tightness in throat. Fever, chills, nonproductive cough. Urinary retention. Suprapubic discomfort. Overweight. Decreased hand grip strength, cannot lift legs off bed, deep tendon reflexes absent. Cranial Nerve V-sensory deficit. Decreased sensation to pin prick and touch. IVIG (intravenous Immunoglobulin)given. Headache. Tingling and numbness resolving, strength returning. Diarrhea. Laboratory data: ECG (electrocardiogram) abnormal, sinus tachycardia, borderline T abnormalities, CSF (cerebral spinal fluid) RBC (red blood cells) 36/uL (H), CBC (complete blood count) with WBC (white blood cell count) 2.2 K/uL (L), Mono 22.0% (H), Eos 6.0% (H), and Neut 0.9 K/uL (L), C-Reactive Protein increased." The patient has not recovered. This case has not been reviewed by agency.
Age: 45.0
Sex: F
Vaccine: FLU(H1N1)
Symptoms: Full blood count, Grip strength decreased, Guillain-Barre syndrome, Headache, Hypoaesthesia
Clinical narrative: Initial report received on 08 December 2009 from CDC, VAERS number 368466-1. A 45-year old female patient had received a first dose of H1N1 (lot number UP005A) on 19 October 2009. The patient has concurrent condition of hyperlipidemia and medical history of GERD (gastroesophageal reflux disease) with Barrett's esophagus, high cholesterol, Influenza A (July 2009), hypertension, hypertriglyceridemia, and allergy to morphine. Surgical history includes: hysterectomy, cholecystectomy, colon polypectomies, cystoscopy with ureter stent, and "T&A" (tonsillectomy and adenoidectomy). The following is verbatim from the report for description of symptoms and reaction. "Onset date of symptoms: 12 November 2009, interval days 24. Seriousness criteria: Hospitalization with extended stay, disabled, and life threatening." "Pain in extremities, numbness, tingling, paralysis. 19 November 2009 ED records received service date 15 November 2009. Assessment: SOB, tingling all extremities, losing coordination. Patient presents short of breath, tingling in arms and legs, unable to control movements. Breathing labored. Skin warm, flushed. Unable to hold arms up. Transported to higher level facility. 23 November 2009 medical records received service dates 15 November 2009 to 20 November 2009. Assessment: Probable Guillain-Barre syndrome with possible associated neurogenic bladder. Community acquired left lower lobe pneumonia. Three days ago patient felt prickly feeling in feet which progressed up legs. Muscle pain and achiness all over. Feet and hands became numb, muscles weak, difficulty moving hands and feet. Diaphragm sore, short of breath, painful to take a deep breath. Choking, gagging, tightness in throat. Fever, chills, nonproductive cough. Urinary retention. Suprapubic discomfort. Overweight. Decreased hand grip strength, cannot lift legs off bed, deep tendon reflexes absent. Cranial Nerve V-sensory deficit. Decreased sensation to pin prick and touch. IVIG (intravenous Immunoglobulin)given. Headache. Tingling and numbness resolving, strength returning. Diarrhea. Laboratory data: ECG (electrocardiogram) abnormal, sinus tachycardia, borderline T abnormalities, CSF (cerebral spinal fluid) RBC (red blood cells) 36/uL (H), CBC (complete blood count) with WBC (white blood cell count) 2.2 K/uL (L), Mono 22.0% (H), Eos 6.0% (H), and Neut 0.9 K/uL (L), C-Reactive Protein increased." The patient has not recovered. This case has not been reviewed by agency.
Age: 45.0
Sex: F
Vaccine: FLU(H1N1)
Symptoms: Lobar pneumonia, Monocyte percentage increased, Movement disorder, Muscular weakness, Myalgia
Clinical narrative: Initial report received on 08 December 2009 from CDC, VAERS number 368466-1. A 45-year old female patient had received a first dose of H1N1 (lot number UP005A) on 19 October 2009. The patient has concurrent condition of hyperlipidemia and medical history of GERD (gastroesophageal reflux disease) with Barrett's esophagus, high cholesterol, Influenza A (July 2009), hypertension, hypertriglyceridemia, and allergy to morphine. Surgical history includes: hysterectomy, cholecystectomy, colon polypectomies, cystoscopy with ureter stent, and "T&A" (tonsillectomy and adenoidectomy). The following is verbatim from the report for description of symptoms and reaction. "Onset date of symptoms: 12 November 2009, interval days 24. Seriousness criteria: Hospitalization with extended stay, disabled, and life threatening." "Pain in extremities, numbness, tingling, paralysis. 19 November 2009 ED records received service date 15 November 2009. Assessment: SOB, tingling all extremities, losing coordination. Patient presents short of breath, tingling in arms and legs, unable to control movements. Breathing labored. Skin warm, flushed. Unable to hold arms up. Transported to higher level facility. 23 November 2009 medical records received service dates 15 November 2009 to 20 November 2009. Assessment: Probable Guillain-Barre syndrome with possible associated neurogenic bladder. Community acquired left lower lobe pneumonia. Three days ago patient felt prickly feeling in feet which progressed up legs. Muscle pain and achiness all over. Feet and hands became numb, muscles weak, difficulty moving hands and feet. Diaphragm sore, short of breath, painful to take a deep breath. Choking, gagging, tightness in throat. Fever, chills, nonproductive cough. Urinary retention. Suprapubic discomfort. Overweight. Decreased hand grip strength, cannot lift legs off bed, deep tendon reflexes absent. Cranial Nerve V-sensory deficit. Decreased sensation to pin prick and touch. IVIG (intravenous Immunoglobulin)given. Headache. Tingling and numbness resolving, strength returning. Diarrhea. Laboratory data: ECG (electrocardiogram) abnormal, sinus tachycardia, borderline T abnormalities, CSF (cerebral spinal fluid) RBC (red blood cells) 36/uL (H), CBC (complete blood count) with WBC (white blood cell count) 2.2 K/uL (L), Mono 22.0% (H), Eos 6.0% (H), and Neut 0.9 K/uL (L), C-Reactive Protein increased." The patient has not recovered. This case has not been reviewed by agency.
Age: 45.0
Sex: F
Vaccine: FLU(H1N1)
Symptoms: Neutrophil percentage decreased, Overweight, Pain, Pain in extremity, Paraesthesia
Clinical narrative: Initial report received on 08 December 2009 from CDC, VAERS number 368466-1. A 45-year old female patient had received a first dose of H1N1 (lot number UP005A) on 19 October 2009. The patient has concurrent condition of hyperlipidemia and medical history of GERD (gastroesophageal reflux disease) with Barrett's esophagus, high cholesterol, Influenza A (July 2009), hypertension, hypertriglyceridemia, and allergy to morphine. Surgical history includes: hysterectomy, cholecystectomy, colon polypectomies, cystoscopy with ureter stent, and "T&A" (tonsillectomy and adenoidectomy). The following is verbatim from the report for description of symptoms and reaction. "Onset date of symptoms: 12 November 2009, interval days 24. Seriousness criteria: Hospitalization with extended stay, disabled, and life threatening." "Pain in extremities, numbness, tingling, paralysis. 19 November 2009 ED records received service date 15 November 2009. Assessment: SOB, tingling all extremities, losing coordination. Patient presents short of breath, tingling in arms and legs, unable to control movements. Breathing labored. Skin warm, flushed. Unable to hold arms up. Transported to higher level facility. 23 November 2009 medical records received service dates 15 November 2009 to 20 November 2009. Assessment: Probable Guillain-Barre syndrome with possible associated neurogenic bladder. Community acquired left lower lobe pneumonia. Three days ago patient felt prickly feeling in feet which progressed up legs. Muscle pain and achiness all over. Feet and hands became numb, muscles weak, difficulty moving hands and feet. Diaphragm sore, short of breath, painful to take a deep breath. Choking, gagging, tightness in throat. Fever, chills, nonproductive cough. Urinary retention. Suprapubic discomfort. Overweight. Decreased hand grip strength, cannot lift legs off bed, deep tendon reflexes absent. Cranial Nerve V-sensory deficit. Decreased sensation to pin prick and touch. IVIG (intravenous Immunoglobulin)given. Headache. Tingling and numbness resolving, strength returning. Diarrhea. Laboratory data: ECG (electrocardiogram) abnormal, sinus tachycardia, borderline T abnormalities, CSF (cerebral spinal fluid) RBC (red blood cells) 36/uL (H), CBC (complete blood count) with WBC (white blood cell count) 2.2 K/uL (L), Mono 22.0% (H), Eos 6.0% (H), and Neut 0.9 K/uL (L), C-Reactive Protein increased." The patient has not recovered. This case has not been reviewed by agency.
Age: 45.0
Sex: F
Vaccine: FLU(H1N1)
Symptoms: Paralysis, Pneumonia, Pyrexia, Red blood cells CSF positive, Retching
Clinical narrative: Initial report received on 08 December 2009 from CDC, VAERS number 368466-1. A 45-year old female patient had received a first dose of H1N1 (lot number UP005A) on 19 October 2009. The patient has concurrent condition of hyperlipidemia and medical history of GERD (gastroesophageal reflux disease) with Barrett's esophagus, high cholesterol, Influenza A (July 2009), hypertension, hypertriglyceridemia, and allergy to morphine. Surgical history includes: hysterectomy, cholecystectomy, colon polypectomies, cystoscopy with ureter stent, and "T&A" (tonsillectomy and adenoidectomy). The following is verbatim from the report for description of symptoms and reaction. "Onset date of symptoms: 12 November 2009, interval days 24. Seriousness criteria: Hospitalization with extended stay, disabled, and life threatening." "Pain in extremities, numbness, tingling, paralysis. 19 November 2009 ED records received service date 15 November 2009. Assessment: SOB, tingling all extremities, losing coordination. Patient presents short of breath, tingling in arms and legs, unable to control movements. Breathing labored. Skin warm, flushed. Unable to hold arms up. Transported to higher level facility. 23 November 2009 medical records received service dates 15 November 2009 to 20 November 2009. Assessment: Probable Guillain-Barre syndrome with possible associated neurogenic bladder. Community acquired left lower lobe pneumonia. Three days ago patient felt prickly feeling in feet which progressed up legs. Muscle pain and achiness all over. Feet and hands became numb, muscles weak, difficulty moving hands and feet. Diaphragm sore, short of breath, painful to take a deep breath. Choking, gagging, tightness in throat. Fever, chills, nonproductive cough. Urinary retention. Suprapubic discomfort. Overweight. Decreased hand grip strength, cannot lift legs off bed, deep tendon reflexes absent. Cranial Nerve V-sensory deficit. Decreased sensation to pin prick and touch. IVIG (intravenous Immunoglobulin)given. Headache. Tingling and numbness resolving, strength returning. Diarrhea. Laboratory data: ECG (electrocardiogram) abnormal, sinus tachycardia, borderline T abnormalities, CSF (cerebral spinal fluid) RBC (red blood cells) 36/uL (H), CBC (complete blood count) with WBC (white blood cell count) 2.2 K/uL (L), Mono 22.0% (H), Eos 6.0% (H), and Neut 0.9 K/uL (L), C-Reactive Protein increased." The patient has not recovered. This case has not been reviewed by agency.
Age: 45.0
Sex: F
Vaccine: FLU(H1N1)
Symptoms: Sensory loss, Sinus tachycardia, Skin warm, Suprapubic pain, Throat tightness
Clinical narrative: Initial report received on 08 December 2009 from CDC, VAERS number 368466-1. A 45-year old female patient had received a first dose of H1N1 (lot number UP005A) on 19 October 2009. The patient has concurrent condition of hyperlipidemia and medical history of GERD (gastroesophageal reflux disease) with Barrett's esophagus, high cholesterol, Influenza A (July 2009), hypertension, hypertriglyceridemia, and allergy to morphine. Surgical history includes: hysterectomy, cholecystectomy, colon polypectomies, cystoscopy with ureter stent, and "T&A" (tonsillectomy and adenoidectomy). The following is verbatim from the report for description of symptoms and reaction. "Onset date of symptoms: 12 November 2009, interval days 24. Seriousness criteria: Hospitalization with extended stay, disabled, and life threatening." "Pain in extremities, numbness, tingling, paralysis. 19 November 2009 ED records received service date 15 November 2009. Assessment: SOB, tingling all extremities, losing coordination. Patient presents short of breath, tingling in arms and legs, unable to control movements. Breathing labored. Skin warm, flushed. Unable to hold arms up. Transported to higher level facility. 23 November 2009 medical records received service dates 15 November 2009 to 20 November 2009. Assessment: Probable Guillain-Barre syndrome with possible associated neurogenic bladder. Community acquired left lower lobe pneumonia. Three days ago patient felt prickly feeling in feet which progressed up legs. Muscle pain and achiness all over. Feet and hands became numb, muscles weak, difficulty moving hands and feet. Diaphragm sore, short of breath, painful to take a deep breath. Choking, gagging, tightness in throat. Fever, chills, nonproductive cough. Urinary retention. Suprapubic discomfort. Overweight. Decreased hand grip strength, cannot lift legs off bed, deep tendon reflexes absent. Cranial Nerve V-sensory deficit. Decreased sensation to pin prick and touch. IVIG (intravenous Immunoglobulin)given. Headache. Tingling and numbness resolving, strength returning. Diarrhea. Laboratory data: ECG (electrocardiogram) abnormal, sinus tachycardia, borderline T abnormalities, CSF (cerebral spinal fluid) RBC (red blood cells) 36/uL (H), CBC (complete blood count) with WBC (white blood cell count) 2.2 K/uL (L), Mono 22.0% (H), Eos 6.0% (H), and Neut 0.9 K/uL (L), C-Reactive Protein increased." The patient has not recovered. This case has not been reviewed by agency.
Age: 45.0
Sex: F
Vaccine: FLU(H1N1)
Symptoms: Urinary retention, White blood cell count decreased
Clinical narrative: Initial report received on 08 December 2009 from CDC, VAERS number 368466-1. A 45-year old female patient had received a first dose of H1N1 (lot number UP005A) on 19 October 2009. The patient has concurrent condition of hyperlipidemia and medical history of GERD (gastroesophageal reflux disease) with Barrett's esophagus, high cholesterol, Influenza A (July 2009), hypertension, hypertriglyceridemia, and allergy to morphine. Surgical history includes: hysterectomy, cholecystectomy, colon polypectomies, cystoscopy with ureter stent, and "T&A" (tonsillectomy and adenoidectomy). The following is verbatim from the report for description of symptoms and reaction. "Onset date of symptoms: 12 November 2009, interval days 24. Seriousness criteria: Hospitalization with extended stay, disabled, and life threatening." "Pain in extremities, numbness, tingling, paralysis. 19 November 2009 ED records received service date 15 November 2009. Assessment: SOB, tingling all extremities, losing coordination. Patient presents short of breath, tingling in arms and legs, unable to control movements. Breathing labored. Skin warm, flushed. Unable to hold arms up. Transported to higher level facility. 23 November 2009 medical records received service dates 15 November 2009 to 20 November 2009. Assessment: Probable Guillain-Barre syndrome with possible associated neurogenic bladder. Community acquired left lower lobe pneumonia. Three days ago patient felt prickly feeling in feet which progressed up legs. Muscle pain and achiness all over. Feet and hands became numb, muscles weak, difficulty moving hands and feet. Diaphragm sore, short of breath, painful to take a deep breath. Choking, gagging, tightness in throat. Fever, chills, nonproductive cough. Urinary retention. Suprapubic discomfort. Overweight. Decreased hand grip strength, cannot lift legs off bed, deep tendon reflexes absent. Cranial Nerve V-sensory deficit. Decreased sensation to pin prick and touch. IVIG (intravenous Immunoglobulin)given. Headache. Tingling and numbness resolving, strength returning. Diarrhea. Laboratory data: ECG (electrocardiogram) abnormal, sinus tachycardia, borderline T abnormalities, CSF (cerebral spinal fluid) RBC (red blood cells) 36/uL (H), CBC (complete blood count) with WBC (white blood cell count) 2.2 K/uL (L), Mono 22.0% (H), Eos 6.0% (H), and Neut 0.9 K/uL (L), C-Reactive Protein increased." The patient has not recovered. This case has not been reviewed by agency.
Age: 9.0
Sex: F
Vaccine: FLU(H1N1)
Symptoms: Abasia, Anxiety, Arthropathy, Asthenia, Axonal neuropathy
Clinical narrative: Initial report received 08 December 2009 from the CDC: VAERS ID 368479-1. A nine-year-old female patient with a history of PE tubes, developed AMAN variant of Guillain-Barre syndrome 11 days after she had received an injection (lot number invalid) on 04 November 2009. The event required an emergency room visit and hospitalization (dates not reported). The patient had not been taking any concomitant medications. An unspecified amount of time prior to vaccination (also reported as two weeks ago), the patient had experienced a febrile flu-like illness with chills, cough and congestion which lasted six days. On 15 November 2009, 11 days after she had received the vaccine, the patient developed acute onset lower extremity weakness, that over the next 24 hours, extended to involve the upper extremities. The event was presumed Guillain-Barre syndrome. the reporter received medical records pertaining to Physical Medicine, Neurology, and Infectious Disease consultations for dates of service 16-17 November 2009. Assessment: Atypical Guillain-Barre Syndrome. These assessments also noted that two weeks ago, the patient experienced a febrile flu-like illness, with chills, cough and congestion which lasted six days. The patient subsequently received the H1N1, and later began to complain of malaise, decreased energy, generalized aches in her neck and legs, weakness in legs and arms, tenderness of deltoids and paraspinal muscles lower back, stumbling, unable to walk or get out of bed without assistance, and decreased reflexes. On 24 November 2009, the reporter received the hospital discharge summary which referenced 16 November 2009 to 23 November 2009 as the dates of service. According to the discharge summary, the patient presented with weakness mostly in her hip flexors with moderate weakness in upper extremities, and she had pain in her back, neck and legs, facial hemiplegia and anxiety. The assessment was AMAN variant of Guillain-Barre syndrome. Corrective treatments included IVIG. According to the reporter, laboratory and diagnostic tests included CSF (within normal limits); ESR 18; urinalysis: ketones 2+, mucous 2+, squamous 1; CMV IGG/IGM weakly (+); CBC-WBC (results not reported); EMG-abnormal, consistent with axonal polyneuropathy; MRI (thoracic and cervical spine)-abnormal, hydromyelia T6-T8. At the time of the report, the diagnostic level of certainty had not been confirmed by CISA and the patient's recovery status was unknown.
Age: 9.0
Sex: F
Vaccine: FLU(H1N1)
Symptoms: Back pain, Blood product transfusion, CSF test normal, Cells in urine, Cytomegalovirus antibody positive
Clinical narrative: Initial report received 08 December 2009 from the CDC: VAERS ID 368479-1. A nine-year-old female patient with a history of PE tubes, developed AMAN variant of Guillain-Barre syndrome 11 days after she had received an injection (lot number invalid) on 04 November 2009. The event required an emergency room visit and hospitalization (dates not reported). The patient had not been taking any concomitant medications. An unspecified amount of time prior to vaccination (also reported as two weeks ago), the patient had experienced a febrile flu-like illness with chills, cough and congestion which lasted six days. On 15 November 2009, 11 days after she had received the vaccine, the patient developed acute onset lower extremity weakness, that over the next 24 hours, extended to involve the upper extremities. The event was presumed Guillain-Barre syndrome. the reporter received medical records pertaining to Physical Medicine, Neurology, and Infectious Disease consultations for dates of service 16-17 November 2009. Assessment: Atypical Guillain-Barre Syndrome. These assessments also noted that two weeks ago, the patient experienced a febrile flu-like illness, with chills, cough and congestion which lasted six days. The patient subsequently received the H1N1, and later began to complain of malaise, decreased energy, generalized aches in her neck and legs, weakness in legs and arms, tenderness of deltoids and paraspinal muscles lower back, stumbling, unable to walk or get out of bed without assistance, and decreased reflexes. On 24 November 2009, the reporter received the hospital discharge summary which referenced 16 November 2009 to 23 November 2009 as the dates of service. According to the discharge summary, the patient presented with weakness mostly in her hip flexors with moderate weakness in upper extremities, and she had pain in her back, neck and legs, facial hemiplegia and anxiety. The assessment was AMAN variant of Guillain-Barre syndrome. Corrective treatments included IVIG. According to the reporter, laboratory and diagnostic tests included CSF (within normal limits); ESR 18; urinalysis: ketones 2+, mucous 2+, squamous 1; CMV IGG/IGM weakly (+); CBC-WBC (results not reported); EMG-abnormal, consistent with axonal polyneuropathy; MRI (thoracic and cervical spine)-abnormal, hydromyelia T6-T8. At the time of the report, the diagnostic level of certainty had not been confirmed by CISA and the patient's recovery status was unknown.
Age: 9.0
Sex: F
Vaccine: FLU(H1N1)
Symptoms: Electromyogram abnormal, Facial palsy, Full blood count, Gait disturbance, Guillain-Barre syndrome
Clinical narrative: Initial report received 08 December 2009 from the CDC: VAERS ID 368479-1. A nine-year-old female patient with a history of PE tubes, developed AMAN variant of Guillain-Barre syndrome 11 days after she had received an injection (lot number invalid) on 04 November 2009. The event required an emergency room visit and hospitalization (dates not reported). The patient had not been taking any concomitant medications. An unspecified amount of time prior to vaccination (also reported as two weeks ago), the patient had experienced a febrile flu-like illness with chills, cough and congestion which lasted six days. On 15 November 2009, 11 days after she had received the vaccine, the patient developed acute onset lower extremity weakness, that over the next 24 hours, extended to involve the upper extremities. The event was presumed Guillain-Barre syndrome. the reporter received medical records pertaining to Physical Medicine, Neurology, and Infectious Disease consultations for dates of service 16-17 November 2009. Assessment: Atypical Guillain-Barre Syndrome. These assessments also noted that two weeks ago, the patient experienced a febrile flu-like illness, with chills, cough and congestion which lasted six days. The patient subsequently received the H1N1, and later began to complain of malaise, decreased energy, generalized aches in her neck and legs, weakness in legs and arms, tenderness of deltoids and paraspinal muscles lower back, stumbling, unable to walk or get out of bed without assistance, and decreased reflexes. On 24 November 2009, the reporter received the hospital discharge summary which referenced 16 November 2009 to 23 November 2009 as the dates of service. According to the discharge summary, the patient presented with weakness mostly in her hip flexors with moderate weakness in upper extremities, and she had pain in her back, neck and legs, facial hemiplegia and anxiety. The assessment was AMAN variant of Guillain-Barre syndrome. Corrective treatments included IVIG. According to the reporter, laboratory and diagnostic tests included CSF (within normal limits); ESR 18; urinalysis: ketones 2+, mucous 2+, squamous 1; CMV IGG/IGM weakly (+); CBC-WBC (results not reported); EMG-abnormal, consistent with axonal polyneuropathy; MRI (thoracic and cervical spine)-abnormal, hydromyelia T6-T8. At the time of the report, the diagnostic level of certainty had not been confirmed by CISA and the patient's recovery status was unknown.
Age: 9.0
Sex: F
Vaccine: FLU(H1N1)
Symptoms: Hemiplegia, Hydromyelia, Hyporeflexia, Malaise, Muscular weakness
Clinical narrative: Initial report received 08 December 2009 from the CDC: VAERS ID 368479-1. A nine-year-old female patient with a history of PE tubes, developed AMAN variant of Guillain-Barre syndrome 11 days after she had received an injection (lot number invalid) on 04 November 2009. The event required an emergency room visit and hospitalization (dates not reported). The patient had not been taking any concomitant medications. An unspecified amount of time prior to vaccination (also reported as two weeks ago), the patient had experienced a febrile flu-like illness with chills, cough and congestion which lasted six days. On 15 November 2009, 11 days after she had received the vaccine, the patient developed acute onset lower extremity weakness, that over the next 24 hours, extended to involve the upper extremities. The event was presumed Guillain-Barre syndrome. the reporter received medical records pertaining to Physical Medicine, Neurology, and Infectious Disease consultations for dates of service 16-17 November 2009. Assessment: Atypical Guillain-Barre Syndrome. These assessments also noted that two weeks ago, the patient experienced a febrile flu-like illness, with chills, cough and congestion which lasted six days. The patient subsequently received the H1N1, and later began to complain of malaise, decreased energy, generalized aches in her neck and legs, weakness in legs and arms, tenderness of deltoids and paraspinal muscles lower back, stumbling, unable to walk or get out of bed without assistance, and decreased reflexes. On 24 November 2009, the reporter received the hospital discharge summary which referenced 16 November 2009 to 23 November 2009 as the dates of service. According to the discharge summary, the patient presented with weakness mostly in her hip flexors with moderate weakness in upper extremities, and she had pain in her back, neck and legs, facial hemiplegia and anxiety. The assessment was AMAN variant of Guillain-Barre syndrome. Corrective treatments included IVIG. According to the reporter, laboratory and diagnostic tests included CSF (within normal limits); ESR 18; urinalysis: ketones 2+, mucous 2+, squamous 1; CMV IGG/IGM weakly (+); CBC-WBC (results not reported); EMG-abnormal, consistent with axonal polyneuropathy; MRI (thoracic and cervical spine)-abnormal, hydromyelia T6-T8. At the time of the report, the diagnostic level of certainty had not been confirmed by CISA and the patient's recovery status was unknown.
Age: 9.0
Sex: F
Vaccine: FLU(H1N1)
Symptoms: Neck pain, Nuclear magnetic resonance imaging abnormal, Pain, Pain in extremity, Red blood cell sedimentation rate increased
Clinical narrative: Initial report received 08 December 2009 from the CDC: VAERS ID 368479-1. A nine-year-old female patient with a history of PE tubes, developed AMAN variant of Guillain-Barre syndrome 11 days after she had received an injection (lot number invalid) on 04 November 2009. The event required an emergency room visit and hospitalization (dates not reported). The patient had not been taking any concomitant medications. An unspecified amount of time prior to vaccination (also reported as two weeks ago), the patient had experienced a febrile flu-like illness with chills, cough and congestion which lasted six days. On 15 November 2009, 11 days after she had received the vaccine, the patient developed acute onset lower extremity weakness, that over the next 24 hours, extended to involve the upper extremities. The event was presumed Guillain-Barre syndrome. the reporter received medical records pertaining to Physical Medicine, Neurology, and Infectious Disease consultations for dates of service 16-17 November 2009. Assessment: Atypical Guillain-Barre Syndrome. These assessments also noted that two weeks ago, the patient experienced a febrile flu-like illness, with chills, cough and congestion which lasted six days. The patient subsequently received the H1N1, and later began to complain of malaise, decreased energy, generalized aches in her neck and legs, weakness in legs and arms, tenderness of deltoids and paraspinal muscles lower back, stumbling, unable to walk or get out of bed without assistance, and decreased reflexes. On 24 November 2009, the reporter received the hospital discharge summary which referenced 16 November 2009 to 23 November 2009 as the dates of service. According to the discharge summary, the patient presented with weakness mostly in her hip flexors with moderate weakness in upper extremities, and she had pain in her back, neck and legs, facial hemiplegia and anxiety. The assessment was AMAN variant of Guillain-Barre syndrome. Corrective treatments included IVIG. According to the reporter, laboratory and diagnostic tests included CSF (within normal limits); ESR 18; urinalysis: ketones 2+, mucous 2+, squamous 1; CMV IGG/IGM weakly (+); CBC-WBC (results not reported); EMG-abnormal, consistent with axonal polyneuropathy; MRI (thoracic and cervical spine)-abnormal, hydromyelia T6-T8. At the time of the report, the diagnostic level of certainty had not been confirmed by CISA and the patient's recovery status was unknown.
Age: 9.0
Sex: F
Vaccine: FLU(H1N1)
Symptoms: Tenderness, Urine abnormality, Urine ketone body present, White blood cell count
Clinical narrative: Initial report received 08 December 2009 from the CDC: VAERS ID 368479-1. A nine-year-old female patient with a history of PE tubes, developed AMAN variant of Guillain-Barre syndrome 11 days after she had received an injection (lot number invalid) on 04 November 2009. The event required an emergency room visit and hospitalization (dates not reported). The patient had not been taking any concomitant medications. An unspecified amount of time prior to vaccination (also reported as two weeks ago), the patient had experienced a febrile flu-like illness with chills, cough and congestion which lasted six days. On 15 November 2009, 11 days after she had received the vaccine, the patient developed acute onset lower extremity weakness, that over the next 24 hours, extended to involve the upper extremities. The event was presumed Guillain-Barre syndrome. the reporter received medical records pertaining to Physical Medicine, Neurology, and Infectious Disease consultations for dates of service 16-17 November 2009. Assessment: Atypical Guillain-Barre Syndrome. These assessments also noted that two weeks ago, the patient experienced a febrile flu-like illness, with chills, cough and congestion which lasted six days. The patient subsequently received the H1N1, and later began to complain of malaise, decreased energy, generalized aches in her neck and legs, weakness in legs and arms, tenderness of deltoids and paraspinal muscles lower back, stumbling, unable to walk or get out of bed without assistance, and decreased reflexes. On 24 November 2009, the reporter received the hospital discharge summary which referenced 16 November 2009 to 23 November 2009 as the dates of service. According to the discharge summary, the patient presented with weakness mostly in her hip flexors with moderate weakness in upper extremities, and she had pain in her back, neck and legs, facial hemiplegia and anxiety. The assessment was AMAN variant of Guillain-Barre syndrome. Corrective treatments included IVIG. According to the reporter, laboratory and diagnostic tests included CSF (within normal limits); ESR 18; urinalysis: ketones 2+, mucous 2+, squamous 1; CMV IGG/IGM weakly (+); CBC-WBC (results not reported); EMG-abnormal, consistent with axonal polyneuropathy; MRI (thoracic and cervical spine)-abnormal, hydromyelia T6-T8. At the time of the report, the diagnostic level of certainty had not been confirmed by CISA and the patient's recovery status was unknown.
Age: 0.18
Sex: M
Vaccine: DTAPIPVHIB, HEP, PNC, RV5
Symptoms: Diarrhoea, Faeces discoloured, Frequent bowel movements, Haematochezia
Clinical narrative: Information received on 10 November 2009 from another manufacturer (report number WAES 09100USA02799). "Information has been received from an office manager concerning a 57 day old male patient with no known drug reactions/allergies or pertinent medical history who on 07-OCT-2009 was orally vaccinated with his first dose of ROTATEQ vaccine (Lot # 663903/0088Y). There was no concomitant medication. The office manager mentioned that on 07-OCT-2009, the patient received ROTATEQ vaccine and developed diarrhea. On 14-OCT-2009 the patient sought medical attention by an office visit an the physician wrote in her office notes "patient had been stooling for 6-7 days, stools greenish at times, and a few drops of blood noted. Child has been acting well at home". No lab tests were performed. It was reported that when the child was seen the frequency of the stools had began to resolve. The physician prescribed "baby acidophilus" and the mother was told to call if he did not improve. It was noted that the office had not received any additional calls from the mother. At the time of the report, the patient had recovered." "Follow-up information has been received from the office manager via telephone call regarding the patient who on 07-OCT-2009 was vaccinated with ROTATEQ vaccine also received PENTACEL vaccine (Lot # C385AA), PREVNAR vaccine (Lot # D575886) and hepatitis B virus vaccine (unspecified) (Manufacturer Unknown) (Lot # 1102Y). The office manager reported that the patient did not experience hematochezia, rather there were a few drops of blood from an anal fissure noted at the 14-OCT-2009 office visit and NEOSPORIN was ordered as treatment. Upon internal review, a few drops of blood in the stool was determined to be an other important medical event. Additional information is not expected."
Age: 83.0
Sex: M
Vaccine: FLU3, PPV
Symptoms: Blood product transfusion, Demyelinating polyneuropathy, Electromyogram abnormal, Guillain-Barre syndrome, Nerve conduction studies abnormal
Clinical narrative: An 83-year-old male patient received SEASONAL INFLUENZA vaccine (manufacturer and lot number not reported), H1N1 pandemic influenza vaccine (manufacturer and lot number not reported) and PNEUMOVAX 23 (Merck, lot not reported) on 16 November 2009. Medical history included COPD, coronary artery disease and a single kidney. Concomitant medications included Combivent, Decadron, Lasix, and Lopressor. Five days post-vaccination, he developed symptoms of Guillian-Barre Syndrome and an EMG and nerve conduction studies revealed demyelinative neuropathy. The patient was treated with IVIG 0.4 g/kg for 5 days and underwent rehabilitation therapy. Outcome was unknown.
Age: 9.0
Sex: M
Vaccine: FLUN(H1N1), FLUN(H1N1), FLUN(H1N1), FLUN(H1N1), FLUN(H1N1)
Symptoms: Asthenia, Asthma, Body temperature increased, Chills, Cough
Clinical narrative: This is second febrile episode since administration of H1N1 nasal spray on 12/08/2009.  First febrile episode has already been previously reported to VAERS system.  On 01/01/2010: 9:30 AM: Scratchy throat, stuffy nose with clear drainage, increased coughing. 3:48 PM: Sleepy and tired and took nap.  10:32 PM:  Complained of feeling very hot inside but showed no signs of sweating. By 12:38 am (January 2nd, 2010) had chills, sore throat, severe nasal stuffiness, axillary temperature of 99.4. Triaminic Day Time Cold and Cough medicine administered.  01/02/2010:  4:12 PM: While eating dinner, patient complained of sudden onset of parietal headache and had chills.  Axillary temperature 102.4, apical pulse 101, respirations 18 and shallow with decreased air exchange at the bases bilaterally.  He was so weak his father had to hold him up to walk from the kitchen table to the bedroom.  Patient was assisted by his dad and I to lay down on the bed.  Triaminic Multi-Symptom Fever administered.  Cold packs placed on forehead and abdomen.  Takara Detox Foot Patch applied to the nape of  his neck as a desparate measure to try and clear out toxins from his body.  We did not apply it to his feet because we expected him to be up and walking again.  Patient was told to drink water and he drank another half cup. 10:32 PM: Takara Detox Foot Patches applied to the underside of all toes. 01/03/2010:  11:50 AM: Myoclonic jerking noted while walking in kitchen. 5:01 PM: Fever 102.2 axillary.  Chills but no sweating.  Heart rate 89, irregularly irregular.  Respirations 18 and clear, unlabored.  Triaminic Multi-symptom Fever administered.  Continuing to drink a lot as instructed by me and pediatrician.  Voided clear, pale yellow urine.  01/04/2010:  6:00 A.M.:  Complained of starting to feel hot inside again. He feels warm to the touch. Triaminic Multi-symptom Fever medicine administered.  1:30 PM: Seen by pediatrician.  Discharge diagnoses: pharyngitis and couth. I asked pediatrician if patient officially has asthma diagnosis and she says yes.  Discharge medications:  Singulair one tablet at bedtime, in addition to his p.r.n. albuterol. Throat culture taken. Nasal tests for RSV and H1N1 done and negative.
Age: 9.0
Sex: M
Vaccine: FLUN(H1N1), FLUN(H1N1), FLUN(H1N1), FLUN(H1N1), FLUN(H1N1)
Symptoms: Culture throat, Fatigue, Feeling hot, Gait disturbance, Headache
Clinical narrative: This is second febrile episode since administration of H1N1 nasal spray on 12/08/2009.  First febrile episode has already been previously reported to VAERS system.  On 01/01/2010: 9:30 AM: Scratchy throat, stuffy nose with clear drainage, increased coughing. 3:48 PM: Sleepy and tired and took nap.  10:32 PM:  Complained of feeling very hot inside but showed no signs of sweating. By 12:38 am (January 2nd, 2010) had chills, sore throat, severe nasal stuffiness, axillary temperature of 99.4. Triaminic Day Time Cold and Cough medicine administered.  01/02/2010:  4:12 PM: While eating dinner, patient complained of sudden onset of parietal headache and had chills.  Axillary temperature 102.4, apical pulse 101, respirations 18 and shallow with decreased air exchange at the bases bilaterally.  He was so weak his father had to hold him up to walk from the kitchen table to the bedroom.  Patient was assisted by his dad and I to lay down on the bed.  Triaminic Multi-Symptom Fever administered.  Cold packs placed on forehead and abdomen.  Takara Detox Foot Patch applied to the nape of  his neck as a desparate measure to try and clear out toxins from his body.  We did not apply it to his feet because we expected him to be up and walking again.  Patient was told to drink water and he drank another half cup. 10:32 PM: Takara Detox Foot Patches applied to the underside of all toes. 01/03/2010:  11:50 AM: Myoclonic jerking noted while walking in kitchen. 5:01 PM: Fever 102.2 axillary.  Chills but no sweating.  Heart rate 89, irregularly irregular.  Respirations 18 and clear, unlabored.  Triaminic Multi-symptom Fever administered.  Continuing to drink a lot as instructed by me and pediatrician.  Voided clear, pale yellow urine.  01/04/2010:  6:00 A.M.:  Complained of starting to feel hot inside again. He feels warm to the touch. Triaminic Multi-symptom Fever medicine administered.  1:30 PM: Seen by pediatrician.  Discharge diagnoses: pharyngitis and couth. I asked pediatrician if patient officially has asthma diagnosis and she says yes.  Discharge medications:  Singulair one tablet at bedtime, in addition to his p.r.n. albuterol. Throat culture taken. Nasal tests for RSV and H1N1 done and negative.
Age: 9.0
Sex: M
Vaccine: FLUN(H1N1), FLUN(H1N1), FLUN(H1N1), FLUN(H1N1), FLUN(H1N1)
Symptoms: Heart rate irregular, Hypoventilation, Influenza serology negative, Myoclonus, Nasal congestion
Clinical narrative: This is second febrile episode since administration of H1N1 nasal spray on 12/08/2009.  First febrile episode has already been previously reported to VAERS system.  On 01/01/2010: 9:30 AM: Scratchy throat, stuffy nose with clear drainage, increased coughing. 3:48 PM: Sleepy and tired and took nap.  10:32 PM:  Complained of feeling very hot inside but showed no signs of sweating. By 12:38 am (January 2nd, 2010) had chills, sore throat, severe nasal stuffiness, axillary temperature of 99.4. Triaminic Day Time Cold and Cough medicine administered.  01/02/2010:  4:12 PM: While eating dinner, patient complained of sudden onset of parietal headache and had chills.  Axillary temperature 102.4, apical pulse 101, respirations 18 and shallow with decreased air exchange at the bases bilaterally.  He was so weak his father had to hold him up to walk from the kitchen table to the bedroom.  Patient was assisted by his dad and I to lay down on the bed.  Triaminic Multi-Symptom Fever administered.  Cold packs placed on forehead and abdomen.  Takara Detox Foot Patch applied to the nape of  his neck as a desparate measure to try and clear out toxins from his body.  We did not apply it to his feet because we expected him to be up and walking again.  Patient was told to drink water and he drank another half cup. 10:32 PM: Takara Detox Foot Patches applied to the underside of all toes. 01/03/2010:  11:50 AM: Myoclonic jerking noted while walking in kitchen. 5:01 PM: Fever 102.2 axillary.  Chills but no sweating.  Heart rate 89, irregularly irregular.  Respirations 18 and clear, unlabored.  Triaminic Multi-symptom Fever administered.  Continuing to drink a lot as instructed by me and pediatrician.  Voided clear, pale yellow urine.  01/04/2010:  6:00 A.M.:  Complained of starting to feel hot inside again. He feels warm to the touch. Triaminic Multi-symptom Fever medicine administered.  1:30 PM: Seen by pediatrician.  Discharge diagnoses: pharyngitis and couth. I asked pediatrician if patient officially has asthma diagnosis and she says yes.  Discharge medications:  Singulair one tablet at bedtime, in addition to his p.r.n. albuterol. Throat culture taken. Nasal tests for RSV and H1N1 done and negative.